Invasive Aspergillosis After Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)
NCT ID: NCT00838643
Last Updated: 2009-02-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
220 participants
OBSERVATIONAL
2002-05-31
2009-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Invasive Fungal Infections in Patients Following Stem Cell Transplant
NCT04619147
Surveillance of Fungal Infections in Bone Marrow/Stem Cell and Organ Transplant Recipients
NCT00026767
Early Detection of Infectious and Noninfectious Lung Diseases Following Allogeneic Hematopoietic Stem Cell Transplantation
NCT06093867
Immune Monitoring After Allogeneic Hematopoietic Stem Cell Transplantation
NCT03233659
Risk Stratification-directed NAC for Prevention of Poor Hematopoietic Reconstitution
NCT03967665
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Allogeneic pts
Adult allogeneic HSCT recipients
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Allogeneic HSCT for a haematological disease
* Written informed consent to the study
Exclusion Criteria
16 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ospedale Santa Croce-Carle Cuneo
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ospedale Santa Croce-Carle Cuneo
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Azienda Sanitaria Ospedaliera santa Croce e Carle
Cuneo, , Italy
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Gal-01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.